Article Details

Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access

Retrieved on: 2021-04-05 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access. View article details on hiswai:

Excerpt

... uses a highly stabilized spike protein from the surface of the coronavirus in order to train the human immune system to recognize and fight infection.

Article found on: news.utexas.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo